Home Other Building Blocks 503-87-7
503-87-7,MFCD00005277
Catalog No.:AA003HVC

503-87-7 | 2-Thiohydantoin

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$21.00   $15.00
- +
5g
95%
in stock  
$50.00   $35.00
- +
10g
95%
in stock  
$62.00   $44.00
- +
25g
98%
in stock  
$125.00   $88.00
- +
100g
98%
in stock  
$446.00   $312.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003HVC
Chemical Name:
2-Thiohydantoin
CAS Number:
503-87-7
Molecular Formula:
C3H4N2OS
Molecular Weight:
116.1417
MDL Number:
MFCD00005277
SMILES:
O=C1CNC(=S)N1
NSC Number:
11772
Properties
Properties
 
Form:
Solid  
MP:
229-231 °C (dec.)(lit.)  
Refractive Index:
1.6550 (estimate)  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
122  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
XLogP3:
-1.1  

Downstream Synthesis Route
503-87-7    487-89-8   
(5Z)-5-((1H-indol-3-yl)methylene)-2-thioxoimidazolidin-4-one 

[1]Khodair,AhmedI.[Phosphorus,SulfurandSiliconandtheRelatedElements,1997,vol.122,p.9-26]

[2]Mendgen,Thomas;Steuer,Christian;Klein,ChristianD.[JournalofMedicinalChemistry,2012,vol.55,#2,p.743-753]

[3]Porwal,Sharad;Chauhan,ShikhaS.;Chauhan,PremM.S.;Shakya,Nishi;Verma,Aditya;Gupta,Suman[JournalofMedicinalChemistry,2009,vol.52,#19,p.5793-5802]

[4]Lin,Xin;Tago,Kenji;Okazaki,Nozomi;So,Takanori;Takahashi,Kyoko;Mashino,Tadahiko;Tamura,Hiroomi;Funakoshi-Tago,Megumi[InternationalImmunopharmacology,2021,vol.100]

[5]Behringer;Schmeidl[ChemischeBerichte,1957,vol.90,p.2510,2514]

[6]Bueyuekbingoel,Erdem;Suezen,Sibel;Klopman,Gilles[IlFarmaco,1994,vol.49,#6,p.443-448]

[7]Khodair,AhmedI.[Phosphorus,SulfurandSiliconandtheRelatedElements,2002,vol.177,#5,p.1157-1173]

[8]Locationinpatent:experimentalpartLewellyn,Kevin;Bialonska,Dobroslawa;Chaurasiya,NarayanD.;Tekwani,BabuL.;Zjawiony,JordanK.[BioorganicandMedicinalChemistryLetters,2012,vol.22,#15,p.4926-4929]

[9]Lewellyn,Kevin;Bialonska,Dobroslawa;Loria,MelissaJ.;White,StephenW.;Sufka,KennethJ.;Zjawiony,JordanK.[BioorganicandMedicinalChemistry,2013,vol.21,#22,p.7083-7090]

[1]CurrentPatentAssignee:ABBVIEINC-WO2007/41048,2007,A2Locationinpatent:Page/Pagecolumn33

[2]Pepino;Pelez;Faillace;Ceballos;Moyano;Argüello[RSCAdvances,2014,vol.4,#104,p.60092-60101]

[3]Yale[JournaloftheAmericanChemicalSociety,1953,vol.75,p.675,676]

[4]Wheeler;Nicolet;Johnson[AmericanChemicalJournal,1911,vol.46,p.472]

[5]Kiec-Kononowicz,Katarzyna;Karolak-Wojciechowska,Janina;Handzlik,Jadwiga[Actapoloniaepharmaceutica,1998,vol.55,#5,p.381-388]

[6]Tang,ShiQing;Lee,YongYangIrvin;Packiaraj,DavidSheela;Ho,HanKiat;Chai,ChristinaLiLin[ChemicalResearchinToxicology,2015,vol.28,#10,p.2019-2033]

[7]Habib,MonicaM.W.;Abdelfattah,MohamedA.O.;Abadi,AshrafH.[ArchivderPharmazie,2015,vol.348,#12,p.868-874]

[8]Bathula,Chandramohan;Ghosh,Shreemoyee;Hati,Santanu;Tripathy,Sayantan;Singh,Shailja;Chakrabarti,Saikat;Sen,Subhabrata[RSCAdvances,2017,vol.7,#6,p.3563-3572]

[1]Mendgen,Thomas;Steuer,Christian;Klein,ChristianD.[JournalofMedicinalChemistry,2012,vol.55,#2,p.743-753]

[2]Tahtouh,Tania;Durieu,Emilie;Villiers,Benoît;Bruyère,Céline;Nguyen,ThuLan;Fant,Xavier;Ahn,KwangH.;Khurana,Leepakshi;Deau,Emmanuel;Lindberg,MattiasF.;Sévère,Elodie;Miege,Frédéric;Roche,Didier;Limanton,Emmanuelle;L’Helgoual’ch,Jean-Martial;Burgy,Guillaume;Guiheneuf,Solène;Herault,Yann;Kendall,DebraA.;Carreaux,François;Bazureau,Jean-Pierre;Meijer,Laurent[JournalofMedicinalChemistry,2022,vol.65,#2,p.1396-1417]

[3]Locationinpatent:experimentalpartGosling,Sandrine;Rollin,Patrick;Tatibouet,Arnaud[Synthesis,2011,#22,p.3649-3660]

[4]Christoff,RebeccaM.;SoaresdaCosta,TatianaP.;Bayat,Saadi;Holien,JessicaK.;Perugini,MatthewA.;Abbott,BelindaM.[BioorganicandMedicinalChemistry,2021,vol.52]

[5]Brun,Elodie;Safer,Abdelmounaim;Carreaux,Franois;Bourahla,Khadidja;L'Helgoua'ch,Jean-Martial;Bazureau,Jean-Pierre;Villalgordo,JoseManuel[Molecules,2015,vol.20,#6,p.11617-11631]

[6]Kim,HyeRim;Lee,HyeJin;Choi,YeonJa;Park,YunJung;Woo,Youngwoo;Kim,SeongJin;Park,MinHi;Lee,HeeWon;Chun,Pusoon;Chung,HaeYoung;Moon,HyungRyong[MedChemComm,2014,vol.5,#9,p.1410-1417]

[7]CurrentPatentAssignee:LATROBEUNIVERSITY-WO2018/187845,2018,A1Locationinpatent:Paragraph0203

[8]Johnson;Kohmann[JournaloftheAmericanChemicalSociety,1915,vol.37,p.1870,1880]

[9]Khodair;El-Subbagh;Al-Obaid[Phosphorus,SulfurandSiliconandtheRelatedElements,1998,vol.140,p.159-181]

[10]Kiec-Kononowicz,Katarzyna;Karolak-Wojciechowska,Janina;Michalak,Barbara;Pekala,Elzbieta;Schumacher,Britta;Mueller,ChristaE.[EuropeanJournalofMedicinalChemistry,2004,vol.39,#3,p.205-218]

[11]Rempel;Atzler;Behrenswerth;Karcz;Schoeder;Hinz;Kaleta;Thimm;Kiec-Kononowicz;Müller[MedChemComm,2014,vol.5,#5,p.632-649]

[12]Kaczor,Aneta;Witek,Karolina;Podlewska,Sabina;Czekajewska,Joanna;Lubelska,Annamaria;Zesławska,Ewa;Nitek,Wojciech;Latacz,Gniewomir;Alibert,Sandrine;Pagès,Jean-Marie;Karczewska,Elzbieta;Kieć-Kononowicz,Katarzyna;Handzlik,Jadwiga[Molecules,2019,vol.24,#3]

[1]JournalofOrganicChemistry,1995,vol.60,p.5494-5503

[2]Nagoya-shiritsuDaigakuYakugakubuKiyo,1959,vol.7,p.42    Chem.Abstr.,1960,p.3388

503-87-7    52562-50-2   
5-<3'-(5-methylindolal)>-2-thiohydantoin 

[1]IlFarmaco,1994,vol.49,p.443-448

Literature

Title: Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry.

Journal: Journal of medicinal chemistry 20120126

Title: Ayşe OngunYüce, et al. Adsorption and inhibition effect of 2-thiohydantoin on mild steel corrosion in 0.1 M HCl. Corrosion Science. 2012, May (58): 86-94.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:503-87-7 Molecular Formula|503-87-7 MDL|503-87-7 SMILES|503-87-7 2-Thiohydantoin |Heterocyclic_Building_Blocks